Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$664M Buy
11,736,426
+1,364,523
+13% +$76.6M 0.49% 22
2014
Q2
$573M Sell
10,371,903
-445,349
-4% -$24.3M 0.45% 27
2014
Q1
$586M Buy
10,817,252
+2,291,278
+27% +$119M 0.52% 22
2013
Q4
$407M Buy
8,525,974
+786,927
+10% +$36M 0.38% 36
2013
Q3
$352M Buy
7,739,047
+675,823
+10% +$30.9M 0.36% 42
2013
Q2
$313M Buy
+7,063,224
New +$315M 0.37% 43

Other funds holding MRK

UBS's MRK Position: Q3 2014 in Review

UBS increased its Merck (MRK) stake by 13% in Q3 2014, buying an estimated $76.6M and bringing the position to 11,736,426 shares worth $664M. The position accounts for 0.49% of the portfolio, ranked #22.

UBS first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. 1,618 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • UBS held 11,736,426 shares of Merck worth $664M as of Q3 2014.
  • UBS bought 1,364,523 Merck shares in Q3 2014, an estimated $76.6M.
  • Merck made up 0.49% of UBS's portfolio in Q3 2014, its #22 holding.
  • UBS first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • 1,618 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.